Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Cell autonomous requirement of endocardial Smad4 during atrioventricular cushion development in mouse embryos.
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
Medications for Multiple Sclerosis and Risk of Malignancy: What Next? Neurotherapeutics. 2021 07; 18(3):1650-1653.
View in:
PubMed
subject areas
Humans
Immunosuppressive Agents
Multiple Sclerosis
Neoplasms
Risk Factors
authors with profiles
Anthony T. Reder